"You've got to breathe, you know" - asthma patients and carers' perceptions around purchase and use of asthma preventer medicines.

CONCLUSIONS: Patient barriers to adherence with asthma preventer medicines including cost are ongoing. Healthcare professionals need to encourage empathic discussion with patients about cost issues. Implications for public health: Asthma patients and carers could benefit from greater involvement and respect within shared decision-making. Healthcare professionals should be aware that cost may be a barrier for patient adherence, and provided with information about the relative costs of guideline-recommended asthma medicines. Patients and healthcare professionals need education around the efficacy of ICS-alone treatment and the rationale behind co-payments, for initiatives around quality use of medicines to succeed. PMID: 30727033 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/30727033?dopt=Abstract

Source: Australian and New Zealand Journal of Public Health - February 6, 2019 Category: International Medicine & Public Health Authors: Davis SR, Tudball J, Flynn A, Lembke K, Zwar N, Reddel HK Tags: Aust N Z J Public Health Source Type: research